Microbiological monitoring of nasal lavage fluid as a method for early detection and prevention of bacterial lung complications in a patient with cystic fibrosis
- Authors: Kondratenko O.V.1, Lyamin A.V.1, Ereshchenko A.A.1, Antipov V.A.1
-
Affiliations:
- Samara State Medical University of the Ministry of Healthcare of the Russian Federation
- Issue: Vol 13, No 1 (2023)
- Pages: 167-170
- Section: SHORT COMMUNICATIONS
- URL: https://journal-vniispk.ru/2220-7619/article/view/126046
- DOI: https://doi.org/10.15789/2220-7619-MMO-2055
- ID: 126046
Cite item
Full Text
Abstract
The severity of complications in cystic fibrosis are determined by microorganisms colonizing the lower airways. Paranasal sinuses can be a reservoir of aggressive pathogens. We have developed a method for collection and primary inoculation of nasal lavage fluid from cystic fibrosis patients for microbiological investigation. As a clinical case illustrating the feasibility of this technique, we describe the dynamics of the microflora composition in a patient with cystic fibrosis. The patient had a clinical and microbiological picture of P. aeruginosa eradication from the lung tissue, owing to which the antibacterial therapy was stopped. Six months later, the microflora in the nasal lavage fluid and sputum were assessed in parallel. The growth of P. aeruginosa (102 CFU/mL) but not P. aeruginosa in sputum was detected. To determine origin of this strain, the degree of genetic relationship between 5 strains obtained from the patient from 2008 to 2016 was assessed based on bacterial protein profiling. A typical strain of P. aeruginosa ATTS 27853 was used as a control. Strains isolated from the patient in 2009 and 2016 were identical suggesting that the antibacterial therapy led to eradication of P. aeruginosa in the lungs, but not in the upper airways. Four months later, the growth of P. aeruginosa was found in sputum. The patient was prescribed to use antibacterial drugs inhaled into paranasal sinuses. Repeated test performed 3 months later resulted in growth of P. aeruginosa 101 CFU/mL from nasal lavage fluid, but not from sputum. The patient was referred to a risk group on airway colonization by pathogen strains derived from the upper airway tract. The clinical example illustrates relevance of conducting a regular microbiological study of nasal lavage fluid in order to early identify clinically significant pathogens to prevent their spread to the lower airway tract.
Full Text
##article.viewOnOriginalSite##About the authors
Olga V. Kondratenko
Samara State Medical University of the Ministry of Healthcare of the Russian Federation
Author for correspondence.
Email: o.v.kondratenko@samsmu.ru
DSc (Medicine), Professor, Department of General and Clinical Microbiology, Immunology and Allergology
Russian Federation, SamaraA. V. Lyamin
Samara State Medical University of the Ministry of Healthcare of the Russian Federation
Email: o.v.kondratenko@samsmu.ru
DSc (Medicine), Professor, Department of General and Clinical Microbiology, Immunology and Allergology
Russian Federation, SamaraA. A. Ereshchenko
Samara State Medical University of the Ministry of Healthcare of the Russian Federation
Email: o.v.kondratenko@samsmu.ru
Assistant Professor, Department of General and Clinical Microbiology, Immunology and Allergology
Russian Federation, SamaraV. A. Antipov
Samara State Medical University of the Ministry of Healthcare of the Russian Federation
Email: o.v.kondratenko@samsmu.ru
Assistant Professor, Department of General and Clinical Microbiology, Immunology and Allergology
Russian Federation, SamaraReferences
- Козлов А.В. Хроническая инфекция дыхательных путей у пациентов с муковисцидозом: обмен железа и его значение // Иммунопатология, аллергология, инфектология. 2019. № 4. С. 62–67. [Kozlov A.V. Chronic respiratory tract infection in patients with cystic fibrosis: metabolism of iron and its significance. Immunopatologiya, allergologiya, infektologiya = Immunopathology, Allergology, Infectology, 2019, no. 4, pp. 62–67. (In Russ.)] doi: 10.14427/jipai.2019.4.62
- Козлов А.В., Гусякова О.А., Ерещенко А.А., Халиулин А.В. Диагностические возможности современного биохимического исследования мокроты у пациентов с муковисцидозом (обзор литературы) // Клиническая лабораторная диагностика. 2019. Т. 64, № 1. С. 24–28. [Kozlov A.V., Gusyakova O.A., Ereshchenko A.A., Khaliulin A.V. Diagnostic possibilities of modern biochemical study of sputum from patients with cystic fibrosis (literature review). Klinicheskaya laboratornaya diagnostika = Russian Clinical Laboratory Diagnostics, 2019, vol. 64, no. 1, pp. 24–28. (In Russ.)] doi: 10.18821/0869-2084-2019-64-1-24-28
- Козлов А.В., Лямин А.В., Жестков А.В., Гусякова О.А., Халиулин А.В. Обмен железа в бактериальной клетке: от физиологического значения к новому классу антимикробных препаратов // Клиническая микробиология и антимикробная химиотерапия. 2022. Т. 24, № 2. С. 165–170. [Kozlov A.V., Lyamin A.V., Zhestkov A.V., Gusyakova O.A., Khaliulin A.V. Iron metabolism in bacterial cells: from physiological significance to a new class of antimicrobial agents. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy, 2022, vol. 24, no. 2, pp. 165–170. (In Russ.)] doi: 10.36488/cmac.2022.2.165-170
- Патент № 2659155 Российская Федерация, МПК G01N 33/487(2006.01). Способ сбора и первичного посева жидкости назального лаважа от пациентов с муковисцидозом для микробиологического исследования: № 2017122649; заявлено 2017.06.27: опубликовано 2018.06.28 / Кондратенко О.В., Лямин А.В., Медведева А.В., Ермолаева А.Д. Патентообладатель: Кондратенко Ольга Владимировна. 6 с. [Patent No. 2659155 Russian Federation, Int. Cl. G01N 33/487(2006.01). Method of collection and primary sowing of nasal lavage fluid from patients with cystic fibrosis for microbiological examination. No. 2017122649; application: 2017.06.27: date of publication 2018.06.28 / Kondratenko O.V., Lyamin A.V., Medvedeva E.D., Ermolaeva A.V. Proprietor: Kondratenko Olga Vladimirovna. 6 p.]
- Berkhout M.C., Rijntjes E., El Bouazzaoui L.H., Fokkens W.J., Brimicombe R.W., Heijerman H.G. Importance of bacteriology in upper airways of patients with cystic fibrosis. J. Cyst. Fibros., 2013, vol. 12, no. 5, pp. 525–529. doi: 10.1016/j.jcf.2013.01.002
- Choi K.J., Cheng T.Z., Honeybrook A.L., Gray A.L., Snyder L.D., Palmer S.M., Abi Hachem R., Jang D.W. Correlation between sinus and lung cultures in lung transplant patients with cystic fibrosis. Int. Forum Allergy Rhinol., 2018, vol. 8, no. 3, pp. 389–393. doi: 10.1002/alr.22067
- Döring G., Hoiby N. Consensus Study Group. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J. Cyst. Fibros., 2004, vol. 3, no. 2, pp. 67–91. doi: 10.1016/j.jcf.2004.03.008
Supplementary files
